Published in Radiology on January 01, 1985
The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol (2009) 1.32
Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol (1994) 1.21
Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother Pharmacol (1989) 1.14
Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatol Res (2014) 1.03
Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg (1987) 1.01
Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study. Cancer Chemother Pharmacol (1992) 0.93
Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol (1994) 0.93
Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol. Br J Cancer (2003) 0.92
Trans-arterial chemoembolization (TACE) in patients with unresectable Hepatocellular carcinoma: Experience from a tertiary care centre in India. Indian J Radiol Imaging (2011) 0.91
A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.90
Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions. Eur Radiol (2006) 0.89
Stage II surgical resection of hepatocellular carcinoma after TAE:a report of 38 cases. World J Gastroenterol (1998) 0.89
Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma. Ann Surg (2001) 0.86
Ablation of recurrent primary liver cancer using 131I-lipiodol. Postgrad Med J (1991) 0.83
Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT). Dig Dis Sci (1998) 0.83
Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol (1992) 0.83
Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model. Mol Imaging Biol (2013) 0.82
Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma. Cancer Chemother Pharmacol (1992) 0.80
Outcomes of 116 patients with hepatocellular carcinoma. Cancer Chemother Pharmacol (1994) 0.80
Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging (2004) 0.80
Intra-arterial alcoholization of advanced hepatocellular carcinoma. Cancer Chemother Pharmacol (1994) 0.80
Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI. Liver Cancer (2015) 0.80
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion. Eur Radiol (2016) 0.78
Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma. J Clin Exp Hepatol (2014) 0.78
Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms. Cancer Chemother Pharmacol (1989) 0.77
Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.76
Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection. Cancer Chemother Pharmacol (1992) 0.76
Patient dosimetry for 131I-lipiodol therapy. Eur J Nucl Med Mol Imaging (2003) 0.76
Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.76
Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Cancer Chemother Pharmacol (1992) 0.76
Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension. Cancer Chemother Pharmacol (1992) 0.76
Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol (2004) 0.76
Liver disease. Postgrad Med J (1994) 0.76
Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma. Int J Nanomedicine (2014) 0.75
Multimodal treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.75
Left brachial approach for transcatheter arterial embolization therapy in patients with hepatocellular carcinoma. Dig Dis Sci (1997) 0.75
Studies on the chemotherapy with 5-fluorouracil in transcatheter arterial chemoembolization (TAE) treated patients with resectable or non-resectable hepatocellular carcinoma. Osaka Study Group on Hepatocellular Carcinoma. Cancer Chemother Pharmacol (1989) 0.75
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
Initiation of the DNA replication of bacteriophage lambda in Escherichia coli K12. J Mol Biol (1977) 3.70
Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci (1997) 3.49
Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg (2012) 3.37
Electroporation of cell membrane visualized under a pulsed-laser fluorescence microscope. Biophys J (1988) 2.83
Organization and expression of the dnaJ and dnaK genes of Escherichia coli K12. Mol Gen Genet (1978) 2.81
CRMP-2 induces axons in cultured hippocampal neurons. Nat Neurosci (2001) 2.70
Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology (1998) 2.58
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Genetic analysis of two genes, dnaJ and dnaK, necessary for Escherichia coli and bacteriophage lambda DNA replication. Mol Gen Genet (1978) 2.30
Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother (1995) 2.12
Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett (1993) 2.10
Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol (1991) 2.03
Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02
Nucleotide sequence of the Escherichia coli dnaJ gene and purification of the gene product. J Biol Chem (1986) 1.99
Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci U S A (1999) 1.93
The nucleotide sequence of the cloned nusA gene and its flanking region of Escherichia coli. Nucleic Acids Res (1984) 1.87
An F factor based cloning system for large DNA fragments. Nucleic Acids Res (1990) 1.82
Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res (2000) 1.81
Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science (1996) 1.81
Acute retinal necrosis as a novel complication of chickenpox in adults. Br J Ophthalmol (1990) 1.81
A mutation in the Pax-6 gene in rat small eye is associated with impaired migration of midbrain crest cells. Nat Genet (1993) 1.81
The AML1/ETO fusion protein activates transcription of BCL-2. Proc Natl Acad Sci U S A (1996) 1.78
The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene (1995) 1.78
Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites. J Chem Neuroanat (1997) 1.76
Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol (2000) 1.73
Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature (1996) 1.69
Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun (1991) 1.67
Normal myelination of anatomic nerve fiber bundles: MR analysis. AJNR Am J Neuroradiol (1998) 1.60
Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans. Antimicrob Agents Chemother (1983) 1.59
Preoperative airway evaluation using multi-slice three-dimensional computed tomography for a patient with severe tracheal stenosis. Br J Anaesth (2004) 1.58
Long terminal repeat sequences of intracisternal A particle genes in the Syrian hamster genome: identification of tRNAPhe as a putative primer tRNA. Nucleic Acids Res (1983) 1.57
DNA sequencing of the Escherichia coli ribonuclease III gene and its mutations. Mol Gen Genet (1985) 1.56
Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology (1994) 1.56
Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol (1988) 1.55
Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease. AJNR Am J Neuroradiol (2001) 1.54
Antenatal diagnosis of biliary atresia (type I cyst) at 19 weeks' gestation: differential diagnosis and etiologic implications. J Pediatr Surg (1995) 1.53
Chromosomal mutations affecting the stability of sex-factors in Escherichia coli. J Mol Biol (1972) 1.52
Isolation of conditionally lethal amber mutations affecting synthesis of the nusA protein of Escherichia coli. Mol Gen Genet (1983) 1.52
Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab (1999) 1.51
Mental retardation in a boy with an interstitial deletion at Xp22.3 involving STS, KAL1, and OA1: implication for the MRX locus. Am J Med Genet (1996) 1.49
L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism (1996) 1.49
Long-term results of operation for carcinoma of the stomach in T1/T2 stages: critical evaluation of the concept of early carcinoma of the stomach. J Am Coll Surg (1995) 1.47
Paxillin alpha and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. Proc Natl Acad Sci U S A (2000) 1.46
Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb. Nature (1993) 1.46
Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Dig Liver Dis (2001) 1.46
Tyrosine phosphorylation of paxillin alpha is involved in temporospatial regulation of paxillin-containing focal adhesion formation and F-actin organization in motile cells. J Biol Chem (2000) 1.44
Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg (2001) 1.41
White coat hypertension in two adolescents. Pediatr Nephrol (1999) 1.41
Porphyromonas gingivalis fimbriae and their synthetic peptides induce proinflammatory cytokines in human peripheral blood monocyte cultures. FEMS Microbiol Lett (1994) 1.41
Factors related to postoperative delirium in patients with lower limb ischaemia: a prospective cohort study. Eur J Vasc Endovasc Surg (2012) 1.40
Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem Biophys Res Commun (2001) 1.39
Hypergonadotropic hypogonadism in a 3-year-old girl with blepharophimosis, ptosis, and epicanthus inversus syndrome. Horm Res (1998) 1.39
Peripheral arterial coil embolization for hepatic arteriovenous malformation in Osler-Weber-Rendu disease; useful for controlling high output heart failure, but harmful to the liver. Intern Med (1999) 1.39
Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys. Antimicrob Agents Chemother (1986) 1.39
Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol (1990) 1.39
Metabolic studies on polychlorinated biphenyls. 3. Complete structure and acute toxicity of the metabolites of 2,4,3',4'-tetrachlorobiphenyl. Chem Pharm Bull (Tokyo) (1973) 1.39
Evaluation of prognostic factors following expansive laminoplasty for cervical spinal stenotic myelopathy. Surg Neurol (1997) 1.38
Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers. J Antimicrob Chemother (1988) 1.38
Factors related to poor visual outcome in patients with retinopathy of prematurity after xenon arc photocoagulation and/or cryocautery. Jpn J Ophthalmol (1998) 1.38
Characterization of genes encoding multi-domain proteins in the genome of the filamentous nitrogen-fixing Cyanobacterium anabaena sp. strain PCC 7120. DNA Res (2001) 1.37
A proposed mild type of acute retinal necrosis syndrome. Am J Ophthalmol (1988) 1.35
In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol (1995) 1.33
Real time visualization of 13N-translocation in rice under different environmental conditions using positron emitting Ttacer imaging system. Plant Physiol (2001) 1.30
Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab (2000) 1.29
Kimura disease: CT and MR findings. AJNR Am J Neuroradiol (1996) 1.28
A transducing lambda phage carrying grpE, a bacterial gene necessary for lambda DNA replication, and two ribosomal protein genes, rpsP (S16) and rplS (L19). Mol Gen Genet (1978) 1.28
Carcinoid tumor occurring in cystic teratoma of the kidney: a case report. Cancer (1976) 1.28
Detection and identification of microcystins in the drinking water of Haimen City, China. Nat Toxins (1996) 1.27
Studies on the secretory potential of acinal cells of the dog submaxillary gland and its ionic dependency. Jpn J Physiol (1967) 1.26
Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neurosci Lett (1996) 1.24
Initiation of DNA replication in a ColE1-type plasmid: isolation of mutations in the ori region. Proc Natl Acad Sci U S A (1980) 1.23
Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J Comp Neurol (1998) 1.23
Metabolism of drugs. LIX. A new metabolite of antipyrine. Biochem Pharmacol (1968) 1.23
Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology (1994) 1.22
Refined x-ray structure of papain.E-64-c complex at 2.1-A resolution. J Biol Chem (1991) 1.21
Retinal ganglion cell death in experimental glaucoma. Br J Ophthalmol (2000) 1.21
Species difference of site-selective glucuronidation of morphine. J Pharmacobiodyn (1991) 1.21
Isolation and developmental expression of male reproductive organ-specific genes in a dioecious campion, Melandrium album (Silene latifolia). Plant J (1996) 1.21
Lung epithelial Na channel subunits are differentially regulated during development and by steroids. Am J Physiol (1995) 1.21
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest (1999) 1.21
Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol (1994) 1.21
Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci U S A (1993) 1.21
Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet (1995) 1.20
Stability of microcystins from cyanobacteria--II. Effect of UV light on decomposition and isomerization. Toxicon (1995) 1.18
Metabolism of drugs. LXX. Further study on antipyrine metabolism. Chem Pharm Bull (Tokyo) (1971) 1.17
Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res (2001) 1.17
Functional cooperation of the dnaE and dnaN gene products in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.16
Escherichia coli mutants suppressing replication-defective mutations of the ColE1 plasmid. Proc Natl Acad Sci U S A (1984) 1.16
Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. J Clin Invest (1973) 1.16
Temperature-sensitive mutations in the alpha subunit gene of Escherichia coli RNA polymerase. J Mol Biol (1980) 1.15